Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PTC Taps Genzyme’s Global Reach, Pocketbook In Ultra-orphan Licensing Deal

This article was originally published in The Pink Sheet Daily

Executive Summary

PTC124 offers new approach for treating lysosomal storage disorders central to Genzyme’s success, as well as other genetic diseases.

You may also be interested in...



Roche Inks A Second Deal With PTC Therapeutics, Pays $30M Upfront

The Big Pharma teams up with a biotech and a patient advocacy foundation to develop treatments for a rare genetic disorder.

AstraZeneca Digs For GEMS In Discovery Deal With PTC

The UK big pharma is the latest to strike deal with PTC for access to its drug discovery platform, this time in oncology.

AstraZeneca Digs For GEMS In Discovery Deal With PTC

The UK big pharma is the latest to strike deal with PTC for access to its drug discovery platform, this time in oncology.

Related Content

Topics

UsernamePublicRestriction

Register

PS068097

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel